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Abstract 
Gcn5-related N-acetyltransferases (GNATs) are 
found in all kingdoms of life and catalyze 
important acyl transfer reactions in diverse cellular 
processes. Although many of their structures 
and/or functions are known, a significant number 
of GNATs remain functionally and structurally 
uncharacterized. Even when the 3D structures of 
these proteins have been determined, most do not 
contain acceptor substrates bound in their active 
sites. The underlying challenge with obtaining 3D 
structures of GNATs with functionally relevant 
ligands bound in their active sites involves 
discerning which ligands are potentially 
functionally relevant for a protein of unknown 
function, and coaxing the protein to bind and 
retain the ligand within the crystal for structure 
determination.  To expand upon existing 
crystallographic strategies for improving ligand 
bound GNAT structures, we have synthesized 
peptide substrate analogs and reacted them with 
CoA in PA4794 protein crystals to form 
bisubstrates. We found two separate mechanisms 
for bisubstrate formation: 1) direct alkylation of 
CoA with a halogenated peptide, and 2) X-ray 
induced radical-mediated alkylation of CoA with 
an alkene peptide. Additionally, we present a 
computational approach for identifying potential 
key residues over the course of the enzymatic 
reaction using these structures in complex with 
bisubstrates. We term this method product-based 
transition-state modeling (PBTSM), as docking 
and molecular dynamics simulations of these 
interactions occur in the reverse direction, i.e. 
from products to substrates.  Our approach is 
widely applicable across the GNAT superfamily 
and can be used to improve the success rate of 
obtaining liganded structures of other GNATs, 
including histone acetyltransferases. 
 
Introduction 
The three-dimensional structures of proteins with 
ligands bound in their active sites are valuable 
tools because they provide a framework for 
determining residues that bind ligands over the 
course of an enzymatic reaction.(1) In the present 
age where new sequencing information greatly 
exceeds the experimental functional annotation of 
genes, liganded structures yield important 
information that can be used to more accurately 
computationally predict protein function or modes 
of ligand binding. Using structural information to 
enhance our understanding of acetyltransferases is 
critically important, since transferring an acetyl 
group from one molecule to another is a 
fundamental biochemical process.  Members of 
the very large Gcn5-related N-acetyltransferase 
(GNAT) superfamily are found in all kingdoms of 
life and play key roles in metabolic and cellular 
processes, including gene regulation, transcription, 
post-translational protein modification, 
detoxification and drug resistance.(2, 3) These 
proteins use an activated acyl-donor, typically 
acetyl-coenzyme A (AcCoA), to transfer an acyl 
group to an acceptor substrate. The identity of the 
acceptor substrate can range from small 
molecules, such as polyamines, antibiotics, or 
arylalkylamines to peptides and proteins.(2, 4, 5) 
Although many proteins belonging to this family 
have been investigated, many members remain 
uncharacterized and would benefit from additional 
structural and functional investigation.  
GNATs have two adjacent but distinct substrate-
binding sites: [1] the acyl donor substrate binding 
site, and [2] the acceptor substrate binding site. 
Hundreds of 3D structures of GNATs have been 
determined and deposited into the Protein Data 
Bank (PDB). While many of these structures have 
AcCoA/CoA bound in the acyl donor substrate 
binding site, it is less common to have ligands 
bound in the acceptor substrate binding site. 
Furthermore, the acyl donor site is highly 
conserved, making protein-CoA binding 
interactions in a newly-sequenced GNAT easier to 
predict. On the other hand, the acceptor substrate 
binding site, which is responsible for specificity, is 
quite diverse among GNATs and more difficult to 
predict ligand binding modes. Obtaining structures 
of GNATs with bound acceptor substrates is 
therefore crucial for understanding these enzymes. 
This has proven to be challenging, for even if the 
function of the protein is known or potential 
acceptor substrates have been identified the 
enzymes often do not bind the ligand in the 
crystal. Thus, new approaches and tools are 
needed to efficiently yield structures with acceptor 
ligands bound so we can more effectively 
understand key substrate recognition elements for 
catalysis across this diverse family of enzymes.  
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One strategy for obtaining liganded structures has 
been to crystallize proteins in the presence of 
bisubstrate inhibitors.(6, 7) These types of 
inhibitors have also been employed in medicinal 
chemistry in the design of more potent inhibitors, 
notably in the area of acetyltransferases and 
kinases to encompass both substrate binding 
pockets.(8, 9) The binding affinity of an enzyme 
for a bisubstrate can be significantly greater than 
that of the substrate alone; therefore, it is expected 
the enzyme will more efficiently bind the ligand in 
the crystal. Many GNAT structures have been 
determined in the presence of bisubstrates where 
the bisubstrate molecule is either synthesized by 
the enzyme itself or chemically prior to 
crystallization.(2, 4, 5, 10-15) 
In our previous work, we used a broad-substrate 
screening assay as a method to identify acceptor 
substrates for an uncharacterized PA4794 GNAT 
enzyme from Pseudomonas aeruginosa and then 
structurally and kinetically characterized it in the 
presence of a dipeptide substrate.(16) We found 
that PA4794 acetylates the dipeptide N-
phenylacetyl glycine lysine (NPAcGK) and 
determined the structure of the ternary complex 
with CoA and acetylated NPAcGK (PDB ID: 
4L8A) (16). Here, we have used the PA4794 
enzyme as a model enzyme from the GNAT 
family to develop a streamlined procedure for 
increasing liganded crystal structures of GNATs in 
the presence of bisubstrates. Our approach was to 
synthesize analogs of the PA4794 substrate and 
have the enzyme catalyze the formation of the 
bisubstrate in the presence of CoA. The 
advantages to this approach are: [1] the synthesis 
and purification procedures for acceptor ligands as 
opposed to full bisubstrates are much simpler, [2] 
it reduces the quantity of costly CoA needed for 
formation of the bisubstrate, [3] many different 
acceptor ligands can be tested using the same 
crystals, and [4] this approach can be used 
regardless of the size of the substrate to be bound. 
This final advantage is important because the 
donor and acceptor substrate binding sites of many 
GNATs are connected by a narrow tunnel, which 
may not allow a fully formed large bisubstrate 
analog to thread through their active sites. 
Allowing each substrate to enter its respective 
binding site separately facilitates formation of a 
bisubstrate even with a large or bulky acceptor 
substrate during crystal soaks or co-crystallization. 
 
In this work, we describe two separate three-
dimensional structures of PA4794 with NPAcGK 
analog-derived bisubstrates formed in the active 
site through two different mechanisms with CoA. 
The first bisubstrate was formed through direct 
alkylation with a reactive substrate, and the second 
bisubstrate was formed through an X-ray induced 
radical-mediated addition to the alkene moiety of 
the substrate analog. Additionally, we present a 
new approach we refer to as product-bound 
transition-state modeling (PBTSM) to simulate the 
reaction pathway of PA4794 catalysis in reverse 
chronological order beginning with products and 
proceeding through the tetrahedral 
intermediate/transition state toward substrate 
binding to explore key interactions within the 
active site along the reaction trajectory. We then 
interrogated some of the key active site residues 
identified through the bound bisubstrate structures 
and PBTSM molecular dynamics analyses by 
preparing point mutations and testing enzymatic 
activity. The approach outlined herein is widely 
applicable across the GNAT superfamily, 
especially those that show a preference for lysine 
acetylation, and can be used to advance the 
knowledge of modes of ligand binding in the 
acceptor site. This will ideally lead to more 
accurate computational methods of functional 
prediction of GNATs and drug design.  
Results 
Design of substrate analogs—We previously 
found that PA4794 acetylates the ε-amino group of 
NPAcGK and prefers to acetylate a C-terminal 
lysine residue of peptides(16), yet its native 
function remains unknown.  We chose this enzyme 
as a model system for exploring formation of 
bisubstrates in GNATs because it is small and 
readily crystallizes, which makes it an ideal 
protein to study mechanisms of ligand binding. To 
begin, we analyzed the 3D structure of the ternary 
complex of PA4794 and its interactions with CoA 
and acetylated NPAcGK (NPAcGAcK) peptide 
(PDB ID: 4L8A) and designed and synthesized 
reactive analogs of the acceptor substrate that 
would react with CoA to form bisubstrates in the 
protein crystal.  We reasoned that electrophilic 
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moieties installed near the ε-amino group of the 
acceptor substrate should be capable of alkylating 
the thiol of free CoA to produce a bisubstrate in 
the active site of the protein.  To mimic the acetyl 
group transferred from CoA to the acceptor but 
with a reactive moiety, we installed an α-
haloacetyl group on the ε-nitrogen of the lysine.  
The α-haloacetyl moiety has been utilized 
extensively as a group to alkylate active site 
residues in proteins(17), and in a similar approach, 
Hwang incorporated an α-haloacetyl moiety as a 
replacement for the acetyl moiety of AcCoA, 
which was able to react with active site residues of 
acetyltransferases that use AcCoA(18). Our 
approach for synthesizing haloacetyl substrates is 
summarized in Scheme 1 and was accomplished 
by reacting NPAcGK with chloroacetyl chloride or 
bromoacetyl chloride to obtain compounds 2a and 
2b, respectively. The PA4794 enzyme-mediated 
formation of bisubstrate 3 occurred in the presence 
of CoA with these compounds in the active site.   
Bisubstrate formation in crystals via an enzyme-
mediated mechanism—We grew crystals of the 
PA4794 protein and soaked them with CoA, 
followed by soaking with the 2a and 2b 
chloroacetyl and bromoacetyl analogs (see 
Experimental Procedures for more details) and 
screened crystals for ligand binding. We found 
both analogs reacted with CoA to form bisubstrate 
3 (Scheme 1, Figure 1A) and exhibited identical 
binding modes in the structures (Figure 1; PDB 
IDs: 5VDB, 5VD6). Although the bromoacetyl 
derivative 2b yielded the same bisubstrate as the 
chloroacetyl derivative 2a, the resolution of the 
structure from bromide 2b was lower, perhaps due 
to the greater reactivity of the bromo compound 
leading to less selective and more random 
reactivity, or simply from greater radiation 
damage to the crystal. Hence, only the structure 
derived from chloroacetyl derivative 2a was 
refined (PDB ID: 5VDB). The bisubstrate was 
formed via an enzyme-mediated mechanism 
whereby the enzyme active site placed the 
electrophilic alkylating moiety in close proximity 
for SN2 displacement of the halide by the thiol of 
CoA.  
Bisubstrate formation in crystals via a radical-
mediated mechanism—When we soaked crystals 
of PA4794 with CoA and the alcohol/alkene 
mixture (4/5) (Scheme 2), our assumption was that 
the alcohol would bind preferentially in the active 
site of the enzyme, given the alcohol’s ability to 
serve as both H-bond donor and H-bond acceptor, 
and the comparable steric volume to the amine 
substrate.  We were surprised to observe formation 
of bisubstrate 6 in the structure (Scheme 2, Figure 
1B, PDB ID: 5VD6). This was curious because 
both alcohol and alkene were expected to be 
chemically unreactive. To determine the 
mechanism of bisubstrate formation between the 
alcohol/alkene analog and CoA, we performed a 
series of tests to determine if it was produced 
enzymatically from the alcohol 4 or alkene 5.  
Treatment of the 4/5 mixture with the PA4794 
enzyme and CoA did not give rise to any 
detectable bisubstrate 6 by HPLC. However, it is 
well known that a thiol can add to an alkene under 
free radical conditions(24), which could have been 
initiated during X-ray data collection, so we tested 
whether or not the 4/5 mixture could produce a 
bisubstrate in the presence of a source of radicals. 
Treatment of 4/5 and CoA with AIBN at 65°C for 
2 hours showed complete consumption of the 
alkene 5 from the mixture and corresponding 
reduction in the concentration of CoA (see 
Supplemental Figure S16). There was no 
detectable effect on the concentration of alcohol 6, 
and the production of a new polar peak close in 
retention time to CoA was shown to be bisubstrate 
6 by mass spectrometry (M¯ observed = 1070.2), 
providing strong evidence that the formation of the 
bisubstrate 6 was due to a radical-mediated 
mechanism from X-ray irradiation during data 
collection. 
Two distinct substrate analog binding modes 
reveal functionally important interactions—The 
bisubstrate analogs formed in the present study 
through either an enzyme- or radical-mediated 
mechanism occupy both the AcCoA and acceptor 
substrate binding sites and enable exploration of 
key interactions in both pockets. The CoA 
moieties of bisubstrates 3 and 6 are bound in 
similar conformations and through similar 
interactions as those of previously determined 
PA4794 structures (PDB IDs: 3PGP, 4KUB, 
4L8A, Figure 1). Bisubstrate 6 binding is similar 
to that of the acylated substrate observed in the 
ternary complex (PDB ID: 4L8A) structure with 
NPAcGAcK (Figure 1C). In particular, the most 
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critical charge-charge interactions of the C-
terminal carboxyl group of NPAcGAcK occur 
with R49 and the main chain nitrogen of N80 as 
well as several water-mediated interactions. The 
phenylacetyl moiety lies against a hydrophobic 
patch composed of residues F118, F27 and P31. 
The moiety corresponding to the C-terminal lysine 
side chain of the bisubstrate 6 (Figure 1B) is 
shorter by four atoms and in an extended 
conformation compared to the acetylated lysine 
side chain of the product NPAcGAcK. The 
bisubstrate compound 3 (Figure 1A) exhibits a 
different binding mode compared to the acylated 
product shown in Figure 1C, but this can be 
attributed to the longer-atom chain connecting the 
lysine mimetic to CoA.  The modified acetyl-
lysine moiety in bisubstrate 3 is extended and is 
not as distorted as in the ternary complex 
structure. Specifically, this is due to a movement 
of the C-terminal carboxyl group of the peptide 
that now interacts with more surface exposed 
R141 instead of R49 (Figure 1A). R141 is located 
closer to the binding pocket opening than R49 and 
allows a more extended conformation of the 
substrate analog moiety, which is slightly less 
buried inside of the protein as compared to 
bisubstrate 6 (Figure 1B). In this case, additional 
interactions are observed between the ε-amino 
group and the acetyl oxygen of the haloacetyl 
substrate analog derivative and the main chain 
oxygen of S116 and main chain nitrogens of N80 
and M81. The two distinct conformations of the 
two bisubstrate analog moieties also induce 
significantly different conformations of Y68. 
Importance of R49 and R141 residues of 
PA4794—The binding mode of the two 
bisubstrates revealed two arginine residues (R49 
and R141) that are implicated as playing a 
potentially important role in binding substrate 
and/or product. To elucidate whether these two 
residues were critical for activity, we constructed 
alanine and glutamine mutants and compared their 
kinetic activity to the wild-type enzyme. We could 
not completely remove the polyhistidine tag from 
all mutants; therefore, we screened the kinetic 
activity of all mutants and wild-type proteins in 
the presence of the tag for this experiment. We 
previously determined the R49Q mutant displayed 
reduced PA4794 catalytic activity, but included it 
here since the tag was not present previously.  (16)  
All five mutants (R49A, R49Q, R141A, R141Q, 
and R49QR141Q) showed a significant decrease 
in activity (between 3.5- and 23-fold decrease) 
compared to the wild-type enzyme, with the most 
severe decrease seen for the double mutant (Figure 
2). Replacing the more surface-exposed arginine 
R141 with glutamine (R141Q) exhibited 
diminished activity compared to the wild-type 
protein, but its replacement with alanine (R141A) 
showed a greater decrease in activity (Figure 2).  
R49 mutations also led to decreased activity 
relative to wild-type, but the glutamine and alanine 
mutants showed opposite effects compared to the 
R141 mutants: the R49A retained greater activity 
relative to R49Q. Regardless, it is clear that both 
of these residues are important for binding peptide, 
and at least one needs to be present for catalysis to 
occur. 
Product-Based Transition-State Modeling 
Approach—To complement our enzyme kinetics 
results and elucidate potential roles of residues 
during catalysis, we used a new in silico modeling 
method we refer to as Product-Based Transition-
State Modeling (PBTSM) (See Experimental 
Procedures for details) to elucidate hypothetical 
substrate and tetrahedral intermediate binding 
modes for PA4794. This method proceeds in 
reverse chronological reaction order beginning 
with reaction products and progressing back 
through the tetrahedral intermediate toward the 
original substrates. The process is summarized in 
Figure 3. Crystallographic data of enzymatic 
reaction products (PDB ID: 4L8A) or bisubstrate 3 
were used as a starting point to systematically 
backtrack through the catalytic intermediate steps 
to computationally guide the placement of atoms 
that are likely to occur during formation of the 
tetrahedral intermediate and substrate binding.  
Active site regions important along the reaction 
trajectory—Using the bisubstrate bound crystal 
structures and the PBTSM protocol, we identified 
a set of important regions of the active site that 
appear to stabilize the tetrahedral intermediate and 
enable the catalytic reaction to proceed. For 
instance, we identified a potential oxyanion hole 
composed of the backbone amide hydrogen of 
M81 near the alpha carbon hydrogen of C29 and 
the backbone amide hydrogen of N80 through a 
water molecule that could stabilize the negatively 
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charged oxygen of the tetrahedral intermediate 
(Figure 4A, blue circle). The water observed in the 
crystal structure is present at a nearly identical site 
as the one observed using the PBTSM protocol, 
which suggests it plays an important role in the 
acetyl transfer mechanism when the system is 
solvated. We also observed that H-bonds were 
formed directly through two backbone carbonyl 
oxygens of S116 and L78 or indirectly through a 
water molecule to stabilize the nucleophilic 
approach of the ε-amino group of NPAcGK during 
formation of the tetrahedral intermediate (Figure 
4A, red circle). Two important arginine residues 
stabilize the C-terminal carboxyl group of the 
NPAcGK substrate (Figure 4A, black square). 
Binding of the carbonyl oxygen atom in the 
oxyanion hole allows the accompanying elements 
involved in formation of the tetrahedral transition 
state intermediate leading to acetyl transfer to be 
recognized. A shallow hydrophobic pocket 
containing L78, I115, Y128 and M81 residues was 
also observed to accommodate the methyl of the 
acetyl group. Finally, the model indicates that the 
sulfur of CoA forms a stabilizing H-bond 
interaction with Y128 and an ordered water 
molecule. This catalytic tyrosine has been 
predicted to play a role as a general acid capable 
of reprotonating CoA after transfer of the acetyl 
group to the acceptor substrate has occurred.(16) 
The ordered water makes further interactions with 
the backbone carbonyl of Y28, while H-bond 
donation varies between the backbone amide of 
F118 and the side chain amide of N121. The 
PBTSM-generated transition state models are 
shown in Figures 4B and 4C.  
Kinetic mechanism of PA4794 toward 
NPAcGK—GNAT enzymes typically use either a 
sequential (direct transfer) mechanism whereby 
both donor and acceptor substrates bind to the 
enzyme simultaneously and the acetyl group from 
AcCoA is transferred directly to the substrate, or 
they use a ping-pong or double-displacement 
mechanism with an indirect transfer of the acetyl 
group via an acetyl-enzyme intermediate. In the 
latter mechanism, AcCoA binds first and transfers 
the acetyl group to a residue in the enzyme active 
site and then CoA leaves. Then the acceptor 
substrate binds and the acetyl group is transferred 
from the enzyme to the acceptor substrate. Since 
our PBTSM modeling experiments predicted a 
tetrahedral transition-state intermediate, which is 
indicative of a direct transfer mechanism, we 
performed enzyme kinetic assays and tested 
kinetic models to experimentally determine which 
kinetic mechanism was preferred for PA4794. 
Similar to other GNATs, we found the PA4794 
protein indeed uses a bisubstrate steady-state 
kinetic mechanism(25, 26) (see Supplemental 
Materials Fig. S1), which infers an overall direct 
transfer of the acetyl group to the acceptor 
substrate through a transition state intermediate. 
Thus, our in vitro and in silico results are 
compatible. 
Mechanistic hypothesis of overall PA4794 
reaction sequence—Based on our combined in 
vitro and in silico results, we propose the sequence 
of substrate approach, acetyl transfer and final 
product release in PA4794 occurs as follows.  Our 
kinetic mechanism results indicate there is no 
specific order of binding of AcCoA and NPAcGK, 
thus both substrates may approach the active site 
in a random order. When the NPAcGK substrate 
binds, its C-terminal carboxylate interacts with 
R141 (located near the binding pocket opening) or 
R49 (located closer to the catalytic center), and the 
lysine moiety approaches the catalytic site as a 
neutral species, having been deprotonated by bulk 
solvent or an unidentified basic residue near the 
active site. (16) The nucleophilic ε-amino group of 
NPAcGK is guided into the correct conformation 
by residues that stabilize the incipient positive 
ammonium species while the acetyl oxygen takes 
its place in the oxyanion hole.  Immediately 
following formation of the tetrahedral 
intermediate, the bond between the carbonyl 
carbon and the sulfur breaks while the negative 
charge on sulfur is stabilized and ultimately 
protonated by Y128.  Reprotonation of Y128 may 
come from bulk solvent or from deprotonation of 
the positively charged ammonium species.  The 
acetylated NPAcGAcK product and CoA would 
then exit the active site and the catalytic cycle 
continues.  Our mechanistic hypothesis for acetyl 
transfer by PA4794 is summarized in Figure 5.  
Discussion 
We have designed two distinct types of tools that 
utilize different mechanisms to form bound 
bisubstrates in GNAT protein crystals: [1] 
chloroacetyl/bromoacetyl derivatives of an 
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acceptor substrate using an enzyme-mediated 
mechanism and [2] addition of a thiol to an alkene 
derivative of acceptor substrate via a radical-
mediated mechanism. We chose to use the 
PA4794 protein of unknown native function from 
P. aeruginosa as a model system to test our 
bisubstrate tools since its crystallization is highly 
reproducible, with fast growth of crystals that 
typically give high-resolution structural data. 
Upon soaking crystals of PA4794 with the 
chloroacetyl derivative of NPAcGK 2a in the 
presence of CoA followed by structure 
determination, we observed that the protein 
enzymatically formed a covalent bisubstrate 
(Figure 1) occupying both AcCoA and acceptor 
substrate sites.  Incubation of PA4794 crystal with 
bromoacetyl substrate 2b yielded an identical 
bisubstrate-bound complex but of lower 
resolution.  
The formation of bisubstrate 6 was unexpected, 
but can be attributed to radiation-induced free-
radical-mediated addition of the thiol to the alkene 
moiety of 5. We hypothesize that bisubstrate 6 was 
not produced enzymatically, but rather through 
exposure to free radicals produced by X-ray 
irradiation during data collection (Scheme 3).  X-
Ray induced chemical modification of specific 
moieties is well documented, and sulfur-
containing residues are particularly 
susceptible.(27)  Scheme 3 presents a mechanistic 
hypothesis for the formation of bisubstrate 6 in the 
active site mediated by hydroxyl radicals produced 
from the interaction of radiation with ubiquitous 
water molecules in and around the active site.  H-
atom abstraction from CoA by a hydroxyl radical 
would yield the thiol radical, which could rapidly 
add to the carbon-carbon double bond of alkene 5 
yielding a secondary radical. This radical could 
then abstract a hydrogen atom from water or a 
nearby residue to obtain bisubstrate 6.  The same 
overall mechanism is expected in the AIBN-
mediated process with H-atom abstraction from 
CoA by the isobutyronitrile radical produced from 
thermal loss of nitrogen from AIBN. The radical-
mediated addition of the thiol moiety of CoA has 
not been previously employed to prepare S-
alkylated derivatives of CoA, and as demonstrated, 
this method may be used to prepare bisubstrates of 
acyltransfer enzymes that employ CoA.  There are 
several reports of the conjugate Michael addition 
of the thiol moiety of CoA to enones(28-30) but 
1,4-addition requires an activating group, typically 
a carbonyl.  
The results of the enzyme-mediated and radical-
mediated bisubstrates combined with PBTSM and 
enzyme kinetics studies provide new information 
regarding key residues that are important for 
PA4794 substrate binding and tetrahedral 
intermediate stabilization. The two different 
binding modes of the bisubstrates showed two 
arginine residues can interact with the carboxylate 
of the NPAcGK substrate: R49 and R141. The 
alkyl side chain of the C-terminal lysine of the 
substrate is less distorted in the bisubstrate 3 and 
bisubstrate 6 structures compared to the ternary 
complex (PDB ID: 4L8A) structure. The 
carboxylate of bisubstrate 3 interacts with R141 
instead of R49 because the bisubstrate is formed 
by sulfur attacking the alpha-CH2 of the 
chloroacetyl group, which provides an extra 
methylene and lengthens the molecule versus the 
sulfur attacking the e-carbon of the alkene for 
formation of bisubstrate 6.  In absence of the 
complex structure with bisubstrate 3, we would 
not have identified R141 as a potentially important 
residue for ligand binding. It appears that either 
arginine residue can contribute to ligand 
stabilization for catalysis, but turnover is 
dramatically decreased when both are not present. 
Since the native substrate of this enzyme is not yet 
known, these results provide new information 
about the architecture of the active site that is 
critical for catalysis. 
 
Our study has expanded upon the tools for forming 
bisubstrates for GNAT structure determination and 
can be applied to other acyltransferases, which 
indicates their broad applicability across enzyme 
families and types of acceptor substrates. In 
particular, our serendipitous radical-mediated 
approach for producing bisubstrates could enhance 
the quantity of acyltransferase crystal structures or 
other enzymes that use CoA obtained in complex 
with specific ligands through employment of 
unactivated alkene derivatives. Since PA4794 is 
specific for acylating a C-terminal lysine residue, 
we consider it a model system for identifying the 
best chemical approaches for studying and 
designing specific inhibitors for other lysine 
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acetyltransferases, such as histone 
acetyltransferases. Furthermore, substrates armed 
with alkylating agents can serve as covalent 
inhibitors with therapeutic application, especially 
given the recent (re)acceptance of covalent 
inhibitors as drugs(31) including those targeting 
protein kinases.(32)Finally, our PBTSM approach 
for modeling the mechanism of an enzyme in 
reverse chronological order offers a new approach 
to utilizing product- or bisubstrate-bound 
structures in predicting key enzyme interactions 
involved in catalysis, and in identifying specific 
amino acid residues for further study. 
 
Experimental Procedures 
 
Materials - All solvents were distilled prior to use, 
and all reagents were used without further 
purification unless otherwise noted.  All synthetic 
reactions were conducted under a nitrogen 
atmosphere.  Silica gel 60A, 40−75 µm (200 × 400 
mesh), was used for column chromatography.  
Aluminum-backed silica gel 200 µm plates were 
used for TLC. 1H NMR spectra were obtained 
using either a 300 MHz spectrometer or a 500 
MHz spectrometer with trimethylsilane (TMS) as 
the internal standard. 13C NMR spectra were 
obtained using a 75 MHz spectrometer or a 125 
MHz spectrometer. HRMS spectra were measured 
on a TOF instrument by electrospray ionization 
(ESI).  Acetyl coenzyme A (AcCoA) and 
coenzyme A (CoA) trilithium salts and N-
phenylacetylglycine lysine (NPAcGK) were 
purchased from Sigma-Aldrich. All other reagents 
for biochemical assays were purchased at the 
highest quality available. 
 
Synthesis of compounds to form bisubstrates — 
NPAcGK (1) was reacted with chloroacetyl 
chloride, and also with bromoacetyl bromide, 
affording electrophilic derivatives 2a and 2b, 
respectively (Scheme 1).  As detailed below, 2a 
and 2b both yielded the same bisubstrate 3 in the 
active site of PA4794.  We employed a classic 
nitrous acid conversion of the primary ε-amine of 
the lysine moiety of NPAcGK to obtain a mixture 
of the alcohol 4 and alkene 5, produced by 
reaction with water, or by elimination, respectively 
(Scheme 2).  We found that the diazonium 
reaction utilizing sodium nitroprusside(23) was 
milder and higher yielding than the traditional 
sodium nitrite and hydrochloric acid.  The mixture 
of 4 and 5 proved to be inseparable with normal-
phase chromatography, nevertheless this provided 
the mixture to test as a potential substrate for the 
enzyme, as well as providing material for 
cocrystallization.   
Synthesis of N6-(2-chloroacetyl)-N2-((2-
phenylacetyl)glycyl)-L-lysine (2a)— K2CO3 (46.0 
mg, 0.33 mmol) was added to a solution of 
NPAcGK 1 (53.0 mg, 0.165 mmol) in deionized 
water (0.55 mL).  The reaction mixture was then 
cooled in an ice bath and chloroacetyl chloride 
(19.8 µL, 28.0 mg, 0.248 mmol) was added under 
nitrogen slowly over several minutes via micro 
syringe, and the reaction was allowed to warm to 
RT over 4 hours.  The pH of the reaction was 
adjusted to 4 by adding 4N HCl before 
liquid/liquid extraction with three portions of 
ethylacetate to recover the desired product. The 
combined organic fractions were washed with 
brine and dried over magnesium sulfate before 
being concentrated under reduced pressure to 
afford the desired chloroacetyl derivative 2a as a 
colorless glass (34.3 mg, 52%):  1H NMR (500 
MHz, 1:3 CDCl3 + d6-DMSO) δ 12.7 (bs, 1H), 
7.91 (t, J=5.5 Hz, 1H), 7.78 (t, J= 5.0, 1H), 7.65 
(d, J=8 Hz, 1H), 7.32-7.21 (m, 5H), 4.37 (dt, 
J=8.5, 5 Hz, 1H), 3.96 (s, 2H), 3.86 (d, J=5.5 Hz, 
2H), 3.56 (d, J=2 Hz, 2H), 3.16 (q, J=6.5 Hz, 2H), 
1.84-1.77 (m, 1H), 1.62 (m, 1H), 1.47 (n, J=7 Hz, 
2H), 1.32 (m, 2H);  HRMS (MH)+ calc for 
C18H25ClN3O5, 398.1483; found, 398.1477. 
 
Synthesis of N6-(2-bromoacetyl)-N2-((2-
phenylacetyl)glycyl)-L-lysine (2b)— In a manner 
analagous to 2a, bromoacetyl derivative 2b was 
prepared as a colorless glass (34 mg, 16%):  1H 
NMR (500 MHz, d6-DMSO) δ 13.03 (bs, 1H), 
8.27-8.23 (m, 2H), 8.08 (d, J=8Hz, 1H), 7.31-7.19 
(m, 5H), 4.17 (dt, J=8.5, 5Hz, 1H), 3.81 (s, 2H), 
3.76 (dd, J=29, 5.5Hz, 1H), 3.73 (dd, J=29, 6Hz, 
1H), 3.48 (s, 2H), 3.04 (q, J=6Hz, 2H), 1.69 (m, 
1H), 1.56 (m, 1H), 1.41-1.24 (m, 4H).  
 
Synthesis of (S)-6-hydroxy-2-(2-(2-
phenylacetamido)acetamido)hexanoic acid (4) 
and (S)-2-(2-(2-phenylacetamido)acetamido)hex-
5-enoic acid (5).  NPAcGK (1) (100 mg, 0.312 
mmol) was dissolved in nano-pure H2O (4mL) 
followed by 4N NaOH (60 µL). The mixture was 
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then heated overnight at 60°C.  Sodium 
nitroprusside (115.1 mg, 0.386 mmol) was added 
to a separate vial and dissolved in H2O (200 µL) 
with gentle heating.  The nitroprusside was then 
added to the NPAcGK basic solution slowly with 
alternating 30 µL portions of nitroprusside 
followed by 30µL of 4N NaOH over 35 min, total 
volume equaling 150 uL of iron catalyst solution 
and 170 uL NaOH. The sample was then allowed 
to stir at 60°C overnight.  The reaction was 
adjusted to pH 4 by adding 4N HCl before 
liquid/liquid extraction with three portions of ethyl 
acetate to recover the desired product.  The 
combined organic fractions were washed with 
brine and dried over magnesium sulfate before 
being concentrated under reduced pressure to 
afford the desired alkene/alcohol product mixture 
4/5 as a colorless oil (30.1 mg, 30%).  RP LC-MS 
analysis on a Surveyor Liquid Chromatography 
system equipped with a Symmetry Shield RP18 
column (5.0 µm, 100 Ǻ) and coupled to an LCQ 
Advantage Mass Spectrum System (Elution with a 
5 % CH3CN (0.1 v/v TFA)-H2O [A]/ 100 % 
CH3CN (0.1 v/v TFA) [B] at 1mL/min flow rate 
and Ttotal = 20 min. Solvent gradient of T0 min = 90 
% A / 10 % B to T15 min = 10 % A / 90 % B until 
gradient switch at T15.1 min back to 90 % A / 10 % B 
until T20 min) was performed. The alcohol 4 
retention time was 5.067 min (MS m/z calc for 
C16H22N2O5 obs 322 and alkene 5 retention time 
was 7.414 min (MS m/z calc for C16H20N2O4 304, 
obs 304).  The product mixture was used without 
further purification.  
Clones and site-directed mutagenesis—The 
PA4794 gene was cloned into the ampicillin 
resistant p11 pET-derived vector as described 
previously(16). Site-directed mutagenesis was 
performed using the Phusion site-directed 
mutagenesis kit from Thermo Fisher Scientific, 
PA4794 WT template DNA, and 5’-
phosphorylated primers to create R49A, R49Q, 
R141A, R141Q, and R49QR141Q mutants. 
Primers included: R49A forward 
atcgccgaagcacgcggcagc, R49Q forward 
atcgccgaacagcgcggca, R49 reverse 
ggcggcggccagctggg, R141A forward 
atcgccgaagcgcacgatccg, R141Q forward 
atcgccgaacagcacgatccg, and R141 reverse 
ggcgcgcggctggtagcc. Mutations are underlined. 
The R49QR141Q mutant was constructed using 
R49Q DNA as template and primers for R141Q. 
See Supplemental Tables S1 and S2 for details of 
mutagenesis conditions. After PCR, the products 
were ligated as described in the kit, transformed 
into E. coli DH5alpha competent cells prepared 
using the Zymo Mix & Go transformation kit, and 
plated on LB-Agar plates containing 100 µg/mL 
ampicillin. Bacterial colonies were submitted to 
Genewiz for DNA sequence confirmation. 
Afterwards, colonies containing plasmids with 
correct sequences were grown and DNA was 
purified and transformed into BL21(DE3) 
competent cells prepared using the Zymo Mix & 
Go transformation kit for protein expression.  
Protein expression and purification—The WT 
PA4794 protein for crystallization was expressed 
and purified as described previously(16). All WT 
and mutant plasmids for kinetic studies were 
transformed into BL21(DE3) cells and grown in 
100 mL of terrific broth (TB) in 500 mL shaker 
flasks on a benchtop shaker at 37°C until the 
OD600nm reached 0.6-0.8.  Cultures were chilled on 
ice and then 0.5 mM IPTG was added to induce 
protein expression overnight at RT on a benchtop 
shaker. The next day cells were harvested by 
centrifugation, resuspended in 15 mL of lysis 
buffer (10 mM Tris-HCl pH 8.3, 500 mM NaCl, 
5% glycerol, 5 mM beta-mercaptoethanol (BME), 
and 5 mM imidazole), sonicated, and centrifuged. 
The supernatant (crude extract) was loaded onto a 
1 mL Hi-Trap FF Ni-affinity column (GE 
Healthcare) equilibrated with buffer A (10 mM 
Tris-HCl pH 8.3, 500 mM NaCl, 5 mM BME) 
using an AKTA Start FPLC system (GE 
Healthcare) at a flow rate of 1 mL/min. Unbound 
sample was washed from the column (5 CVs of 
buffer A plus 25 mM imidazole) and purified 
protein was eluted from the column with buffer B 
(5 CVs of buffer A plus 500 mM imidazole). 
Proteins were desalted using a PD-10 column (GE 
Healthcare) by gravity flow into buffer A and 
concentrated to <0.5 mL using Sartorius 6 mL 
concentrators with 10K MWCO. The polyhistidine 
tag on the WT protein was cleaved using TEV 
protease (purified as described previously(16)) in a 
20:1 ratio of purified protein to TEV protease in 
Slide-a-lyzer dialysis tubes (Thermo Fisher 
Scientific). The cleavage buffer (50 mM Tris-HCl 
pH 8.3, 300 mM NaCl, 5% glycerol, 1 mM DTT) 
was added to the bottom portion of the dialysis 
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tube and incubated at 37°C on an oscillating 
shaker for 2 hrs. The buffer in the bottom of the 
dialysis tube was discarded, fresh cleavage buffer 
was added to the tube, and the sample was at 
incubated at 4°C on an oscillating shaker in a cold 
cabinet overnight. The sample was centrifuged to 
remove any precipitate and the soluble fraction 
was loaded onto a 1 mL HiTrap FF column (GE 
Healthcare). Protein was desalted using a PD-10 
column into buffer A and concentrated as 
described above and stored in aliquots at -80°C. 
All proteins were purified to near homogeneity as 
assessed by SDS-PAGE. We typically remove the 
polyhistidine tag from this protein prior to 
performing enzyme kinetics because it binds the 
tag in its active site (33); however, the efficiency 
of TEV cleavage was not consistent for all mutants 
and we could not separate the cleaved from non-
cleaved proteins. Therefore, we prepared a set of 
proteins, including all mutant and WT, with the 
tag remaining for kinetic analyses in order to 
compare all proteins consistently.  
Colorimetric Ellman’s enzyme assays—Kinetic 
characterization of WT and mutant proteins: 
Substrate saturation curves of NPAcGK for the 
WT and mutant enzymes were performed using 
the Ellman’s colorimetric assay and analyzed as 
described previously(16, 34) with the following 
modifications. Since the polyhistidine tag could 
not be completely removed for all mutants, we 
decided to compare the kinetics of all proteins 
used for the kinetic analysis with the tags 
remaining at their N-termini for consistency. The 
enzyme concentration for WT, R49A, R49Q, 
R141A, R141Q, or R49QR141Q in the enzyme 
assay was 2.5 (WT) and 11.2 µM (all mutants). 
Determination of kinetic mechanism: The most 
compatible model for the WT PA4794 kinetic 
mechanism was determined as described 
previously(25) where a series of four NPAcGK 
substrate saturation curves at set concentrations of 
AcCoA (0.1, 0.25, 0.5, 1 mM) were produced 
using cleaved 2.1 µM WT protein while varying 
NPAcGK concentrations from 0-25mM. Substrate 
analog test: To determine if the PA4794 enzyme 
could acetylate the NPAcGK alcohol analog, we 
performed the following assay using the 4/5 
mixture since the two compounds could not be 
separated from each other. A 50 mM stock of the 
4/5 mixture was prepared by dissolving the 
compounds in 50 mM Bicine pH 9.0 buffer. 
Substrate saturation curves were produced in 
triplicate using reactions (50 µL volume) 
containing 50 mM Bicine pH 9.0 buffer, 0.5 mM 
AcCoA, and varying concentrations of the 
alcohol/alkene mixture (from 0-25 mM). The 
reactions were initiated with 5.1 µM WT cleaved 
enzyme and were processed as described 
previously(16). Enzyme-mediated formation of 
bisubstrate with alkene: To determine if the 
bisubstrate formation was enzyme-mediated, we 
prepared a 25 mM stock solution of the 4/5 
mixture in 50 mM Bicine pH 9.0. Reactions (50 
µL) contained 50 mM Bicine pH 9.0, 5 mM CoA, 
and 10 mM 4/5 mixture, and were initiated using 
either 1.1 or 11 µM cleaved WT enzyme and 
incubated at RT for 19 hrs. Control reactions 
included: 1) no enzyme, 2) no enzyme and no 4/5  
mixture, 3) and no enzyme, no 4/5  mixture, and 
no CoA. The next day 150 µL of MeOH was 
added to each sample, centrifuged for 5 min at 
21,000 x g, and transferred to an HPLC vial for 
analysis. No precipitate was observed. 
HPLC analysis of enzyme-mediated formation of 
bisubstrate with alkene: To analyze possible 
PA4794 enzyme-mediated formation of the 
bisubstrate, high-performance liquid 
chromatography (HPLC) analysis was performed 
according to a previously described HPLC 
method(35)  with the following modifications. 
Samples were analyzed on a Hewlett Packard 
1050 series HPLC system with diode array 
detector (DAD) set to monitor 205 nm using a 
Regis Little Champ II ODS guard column coupled 
to a SymmetryShield RP18, 3.3 µm, 100A column. 
Filtered samples were loaded into standard size 
VWR autosampler HPLC vials fitted with 300µL 
conical glass inserts. Samples were eluted with a 
5% acetonitrile (0.1% v/v TFA)-H2O [A]/ 5% 
acetonitrile (0.1% v/v TFA) [B] at 1 mL/min flow 
rate.  A solvent gradient from 90% A / 10% B at 
time 0 to 10% A / 90% B at time 15 min was used. 
At time 15.1 min the gradient was switched to 
90% A / 10% B for a re-equilibration period until 
the end of the method at time 25 min. Samples 
were additionally analyzed on a Surveyor Liquid 
Chromatography system equipped with a 
SymmetryShield RP18, 5.0 µm, 100A column and 
a UV-Vis unit set to monitor absorbance between 
200-275 nm. The LC system was coupled to an 
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LCQ Advantage Mass Spectrometer System 
monitoring both positive and negative modes 
under full scan. 
HPLC analysis of radical-mediated AIBN 
formation of bisubstrate with alkene: The radical-
mediated AIBN reaction was used to test for 
formation of the bisubstrate with the 4/5 mixture 
in the presence of coenzyme A.  A sample of the 
4/5 mixture (2.2 mg, ~6.8 µmol) was dissolved in 
HPLC grade methanol (35 µl) followed by 
addition of AIBN (300 mg, 0.34 µmol) and CoA 
(5.3 mg, 6.8 µmol).  The reaction was stirred at 
60°C over four hours and then diluted with 2.0 mL 
of methanol. HPLC analysis was performed as 
described above.  
AIBN mediated bisubstrate sample purification 
& LC MS/MS analysis: Solid-phase extraction 
(SPE) was performed using an AASP Vac-Elut 
Model AI 6000 vacuum manifold from 
Analytichem International and was regulated to 
maintain a flowrate of 3-5 mL/min.  The desalting 
procedure was performed using a 200 mg Oasis 
HLB resin (Waters) extraction cartridge loaded 
with a 3 mg sample of concentrated bisubstrate as 
follows: The SPE cartridge was conditioned with 1 
mL acetonitrile followed by 1 mL of 0.1M 
triethylammonium acetate buffer (TEAA) at pH 7.  
The crude sample was dissolved in 500 µL 0.1 M 
TEAA and loaded onto the SPE cartridge.  The 
cartridge was washed with 2 x 5 mL of 0.1 M 
TEAA followed by 5 mL DI H2O to remove salts 
from the sample.  The sample was recovered using 
three consecutive 500 µL elutions of 70% 
acetonitrile-H2O.  The purified analyte was then 
analyzed with direct inject mass spectroscopy on a 
LCQ Advantage Mass Spectrometer System 
monitoring negative mode under full scan. Mass 
calc for C37H56N9O20P3S 1071.26, found 1070.21.  
A MS2 fragmentation ion spectrum was also 
obtained for the ion peak at 1070 with a 30% 
fragmentation power.(36) 
Protein Crystallization—PA4794 protein crystals 
were grown using vapor diffusion and hanging 
drop setups. The crystallization drops were a 1 µl : 
1 µl mixture of protein solution at 9 mg/mL and 
the precipitant composed of 2M ammonium 
sulfate and 100 mM Bis-Tris pH 6.5. To obtain 
structures of the PA4794 protein in the presence of 
bisubstrates, apo-form crystals were soaked first 
with 5mM CoA, followed by adding 10mM of the 
N6-(2-chloroacetyl)-N2-((2-phenylacetyl)glycyl)-
L-lysine 2a or  mixture of (S)-6-hydroxy-2-(2-(2-
phenylacetamido)acetamido)hexanoic acid (4) and 
(S)-2-(2-(2-phenylacetamido)acetamido)hex-5-
enoic acid (5). Prior to data collection, each crystal 
was transferred to a solution containing a 2:1 
mixture of precipitant solution and ethylene glycol 
and immediately cryo-cooled in liquid nitrogen. 
Tracking and analysis of the experiments were 
performed with the LabDB(37) and XtalDB(38) 
data management system. 
 
Data collection, structure determination and 
refinement—Data collection was performed at the 
21-ID-G beam line of the Life Sciences 
Collaborative Access Team at the Advanced 
Photon Source (APS). Data were collected at a 
temperature of 100 K and processed with HKL-
2000(39). The PA4794 structure (PDB ID: 4L8A) 
was used as a model to solve the structure of 
PA4794 in complex with bisubstrates by 
molecular replacement (MR) using HKL-3000 
(40) coupled with MOLREP(41).  Refinement was 
performed using HKL-3000 coupled with 
REFMAC5(42), COOT(43, 44) and selected 
programs from the CCP4 package (Collaborative 
Computional Project, 1994). The atom B-factors 
were refined using anisotropic refinement. 
Structure validation was performed using 
MOLPROBITY(45) and ADIT(46). Structures of 
PA4794 in complex with two bisubstrates were 
determined: (A) (3R,20S)-1-(((((((2R,3S,4R,5R)-
5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-
(phosphonooxy)tetrahydrofuran-2-
yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)p
hosphoryl)oxy)-3-hydroxy-2,2-dimethyl-4,8,14-
trioxo-20-(2-(2-phenylacetamido)acetamido)-12-
thia-5,9,15-triazahenicosan-21-oic acid (3) and (B) 
(2R)-5-((2-(3-((2R)-4-(((((((2R,3S,4R,5R)-5-(6-
amino-9H-purin-9-yl)-4-hydroxy-3-
(phosphonooxy)tetrahydrofuran-2-
yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)p
hosphoryl)oxy)-2-hydroxy-3,3-
dimethylbutanamido)propanamido)ethyl)thio)-2-
(2-(2-phenylacetamido)acetamido)pentanoic acid 
(6). The coordinates, structure factors, and 
intensities were deposited in the PDB (PDB IDs: 
5VD6, 5VDB). Statistics describing 
crystallographic data collection and refinement are 
summarized in Table 1. 
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In-Silico Modeling—Modeling and molecular 
dynamics simulations were performed using 
Chemical Computing Group’s MOE (Molecular 
Operating Environment).[ Molecular Operating 
Environment (MOE), 2013.08;] (47) To 
understand the critical components of the PA4794 
acetyl transfer reaction mechanism, the crystal 
structure of the PA4794 ternary complex (PDB 
ID: 4L8A) and the bisubstrate co-crystal structure 
obtained from soaking chloroacetyl derivative 2a 
and CoA (PDB ID: 5VDB, Figure 1A) were used 
to model the tetrahedral intermediate expected to 
be generated during the acetyl transfer reaction of 
AcCoA (donor) and NPAcGK (acceptor).  Two 
separate models were prepared as starting points 
using MOE’s utility Structure-Prep. (47) First, the 
products of the enzymatic reaction were modeled 
based on the conformation of bisubstrate 3 in 
5VDB using MOE’s utility 3D Builder by first 
removing the bond between the bisubstrate sulfur 
of CoA and the acetyl methyl carbon of 
NPAcGAcK. This left NPAcGK-εNHAc and 
HSCoA ligands bound to the active site of the 
model. The 4L8A structure(16) already possessed 
these two products so no remodeling of the second 
model was necessary.  Next, the models were 
solvated in a simple water box at pH of 7.4 and 
treated with NaCl counter ions. Periodic boundary 
conditions were enabled, and the hydrogen 
bonding network of the model was optimized by 
automatic sampling of different tautomer/protomer 
states using Protonate3D(48). Atoms were then 
optimized with a short, localized molecular 
minimization (MM) using the MOE utility 
QuickPrep with receptor atom tether constraint 
strength set to 10 and atoms further then 8 Å from 
the ligand fixed. Refinement proceeded until a 
RMS Gradient of 0.1 kcal/mol/Å was reached. 
Molecular Dynamics parameters were set to 
globally minimize the protein, ligand and solvent 
atoms of the models. To minimize variables during 
in the simulation, the atoms involved in H-bonding 
between the beta-alanine to beta-cysteamine amide 
bond were tethered to maintain the occupancy of 
the CoA in the active site during the annealing 
process. Simulated annealing was then performed 
on the product bound models. Molecular dynamics 
experiments were performed using a NPA 
algorithm with a Amber12:EHT force field, an 
initial warming from 0-311 K over 100 ps with 
equilibration at 311 K over 100 ps, and a 200 ps 
production stage at constant temperature followed 
by a 100 ps cooling stage from 300-0 K.   
The two equilibrated and optimized NPAcGK-
εNAc + HS-CoA product models were then 
remodeled to produce tetrahedral intermediate 
models. Another local minimization using 
QuickPrep was performed to correct the distorted 
atomic bonds resulting from manual ligand 
modification. Molecular dynamics simulations 
were performed to optimize the residue 
interactions responsible for stabilizing the 
tetrahedral intermediate. A second simulated 
annealing simulation was performed as described 
above except a 700 ps production stage at constant 
temperature followed by a 100 ps cooling stage 
from 300-0 K was used. Binding affinities for the 
molecular dynamics results were calculated based 
on tetrahedral intermediates (Figure 6).  Similar 
modeling was performed using the MOE 3D Build 
utility to systematically transform the tetrahedral 
intermediates for each model into corresponding 
substrate NPAcGK + AcCoA models.  The bond 
between N6 and the carbon of the acetyl was 
deleted and the double bond of the carbonyl was 
reestablished, and the carbonyl oxygen and the 
nitrogen atoms were given a neutral charge.  Then, 
a third and final molecular dynamics simulation 
was performed to validate the model using the 
same parameters as described above except with a 
200 ps equilibration stage and 700 ps production 
stage at constant temperature and a 100 ps cooling 
stage from 300-0 K. A short molecular mechanic 
minimization was performed and binding affinities 
were calculated (Figure 8).  The differences in 
binding modes between the two respective models 
for products, tetrahedral intermediates and 
substrates were compared to determine the likely 
residues critical for acetyl transfer and the most 
reasonable substrate approach to the active site. 
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TABLE 1. Crystallographic data collection and refinement statistics. *  Highest resolution shell 
values are shown in parentheses. ** 5% of reflections were randomly assigned to the Rfree set. 
Complex bisubstrate analog 3 bisubstrate analog 6 
PDB code 5VDB 5VD6 
Data collection   
Space group P21212 P21212 
Unit cell   
a, b, c (Å) 57.3, 76.1, 39.2 57.1, 76.2, 39.0 
α, β, γ (°) 90.0, 90.0, 90.0 90.0, 90.0, 90.0 
Resolution (Å)* 1.40 (1.40 - 1.42) 1.20 (1.20 - 1.22) 
Observed reflections 237096 325622 
Rmerge 0.053 (0.800) 0.067 (0.664) 
<I>/<σ(I)>* 39.9 (2.0) 41.3 (2.2) 
Completeness (%)* 99.9 (100.0) 99.0 (97.8) 
Redundancy* 6.9 (6.8) 6.1 (5.5) 
Refinement   
Rwork (%)/Rfree (%)** 14.5 / 17.0 13.2 / 16.3 
No. atoms   
Protein 1279 1302 
Ligand/Ion 131 100 
Water 188 253 
B factors   
Wilson B factor (Å2) 17.7 13.6 
Protein (Å2) 19 16 
Ligand/Ion (Å2) 29 26 
Water (Å2) 36 32 
Structure quality   
R.m.s. deviations   
bond length (Å) 0.01 0.01 
bond angles (°) 1.2 1.5 
Statistics   
Ramachandran Favored (%) 99.4 98.1 
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FIGURES 
 
Scheme 1.  Synthesis of a-haloacetyl derivatives of NPAcGK 2a (X = Cl) and 2b (X = Br) and enzyme-
mediated formation of bisubstrate 3. 
 
 
 
Scheme 2.  Formation of the alcohol/alkene mixture (4 and 5) from NPAcGK, and radical-mediated 
reaction of CoA with alkene 5 to form the covalent bisubstrate 6. 
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Scheme 3.  Mechanistic hypothesis for the formation of bisubstrate 6 from CoA and alkene 5. 
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Figure 1. Comparison of binding products and bisubstrate 3 and 6 analogs. PA4794 is shown as a 
gray ribbon diagram. Residues 19-37 are not shown for clarity. (A) PA4794 in complex with bisubstrate 
analog 3 synthesized from CoA and chloroacetyl derivative 2a determined at 1.4 Å resolution. (B) 
PA4794 in complex with bisubstrate analog 6 synthesized from CoA and alcohol/alkene mixture 4/5 
determined at 1.2 Å resolution. (C) Ternary complex structure of PA4794 with the bound reaction 
products CoA and N6-acetylated NPAcGAcK. (D) 2Fo-Fc electron density map of the bound bisubstrate 
analog 3 (σ=1.0). (E) 2Fo-Fc electron density map of the bound bisubstrate analog 6 (σ=1.0). 
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Figure 2. Substrate saturation curves for wild-type and R49 and R141 mutants.  Steady-state 
enzyme kinetic experiments were performed by holding AcCoA concentration constant at 0.5 mM and 
varying NPAcGK peptide concentration. Standard deviations for triplicate reactions for all proteins are 
shown. See Experimental procedures for more details.  
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Figure 3. Product-Based Transition-State Modeling (PBTSM). Protocol for systematic remodeling of 
tetrahedral intermediate and substrate binding modes from product or bisubstrate bound crystal structures. 
Molecular minimization (MM) and molecular dynamics (MD) stages in the protocol are shown. Further 
details are presented in Experimental Procedures. 
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Figure 4. Product-Based Transition-State Modeling (PBTSM) Analysis. A) Schematic diagram of 
tetrahedral transition state intermediate indicating important regions of substrate-enzyme interactions in 
the active site, including interactions that anchor the substrate C-terminal carboxylate (black square), the 
oxyanion hole (blue circle), and stabilizing interactions for substrate amine approach (red circle). B) 
PBTSM-generated transition state model based on PA4794 co-crystal structure with products bound 
(PDB ID: 4L8A) shown in light green. C) PBTSM-generated transition state model based on PA4794 
structure in complex with bisubstrate 3 shown in cyan. The CoA moiety of the tetrahedral intermediate is 
shown in dark green and protein side chains are in orange. Amino groups are in dark blue, oxygens in red, 
sulfurs in yellow, and waters as red and white spheres.  
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Figure 5. Proposed chemical mechanism for PA4794 acetyltransfer. Residues that occupy the 
oxyanion hole are in blue, AcCoA substrate is in green, Y128 that acts as the general acid is in brown, 
residues that stabilize the epsilon amino group are in red, and NPAcGK peptide with stabilizing arginine 
residues in black. 
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Table S1. PA4794 Mutagenesis Conditions.  
Mutants were constructed using the conditions outlined below. All mutants were made using WT 
DNA as template except R49QR141Q, which used R49Q DNA as template. Variations to the 
procedure included adding 2% DMSO to the reaction for the R49A mutant and changing the 
annealing temperature to 68°C for R49A, R141A, R141Q and 73°C for R49Q and R49QR141Q 
mutants. 
Original reagents and volumes from Phusion Site Directed Mutagenesis Protocol: 
Component 50 µL Reaction Final Concentration 
Water 26 µL - 
5X Phusion HF Buffer 10 µL 1x 
10 mM dNTPs 1 µL 200 µM 
Forward Primer (10µM) 5 µL 1 µM 
Reverse Primer (10µM) 5 µL 1 µM 
Template DNA (10ng/µL) 2.5 µL 25 ng 
Phusion Hot Start DNA Polymerase 0.5 µL 0.02 U/µL 
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Table S2. Original Thermocycler conditions from Phusion Site Directed Mutagenesis Protocol: 
 Temperature (o C) Time Number of Cycles 
Initial Denaturation 98 30 seconds 1 
Denaturation 98 10 seconds 25 
Anneal 70 30 seconds 25 
Extension 72 5 minutes 25 
Final Extension 72 7 minutes 1 
“Hold” 4 ∞ - 
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Figure S1. Series of NPAcGK curves at varying concentrations of AcCoA. The fitting for the 
kinetic model that was most compatible with the data, i.e. gave the best AICc value, is shown. 
AICc values for each model are shown in the table beneath the figure. AcCoA concentrations 
were 0.1, 0.25, 0.5, and 1mM for filled circles, open triangles, filled triangles, and open upside 
down triangles, respectively. The most compatible model was the bireactant steady-state 3 model 
as described in 1. A represents NPAcGK substrate and B is AcCoA. 
 
 
 
Model 
 
AICc Value 
I : Bireactant Ordered A-First -214  
II : Bireactant Ordered B-First -248 
III : Bireactant Ping-Pong -309 
IV : Bireactant Cooperative Ping-Pong -343 
V : Bireactant Random Independent -270 
VI : Bireactant Random Cooperative -329 
VII : Bireactant Modified Hill -335 
VIII : Bireactant Random Steady-State -348 
IX : Bireactant Random Steady-State 2 -350 
X : Bireactant Random Steady-State 3 -351 
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Figure S2. 1H NMR for N6-(2-chloroacetyl)-N2-((2-phenylacetyl)glycyl)-L-lysine (2a)
	  
	  
S-­‐6	  
	  
Figure S3. Homonuclear 1H-1H COSY NMR for N6-(2-chloroacetyl)-N2-((2-
phenylacetyl)glycyl)-L-lysine (2a)
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Figure S4. Mass Spectrum for N6-(2-chloroacetyl)-N2-((2-phenylacetyl)glycyl)-L-lysine (2a) 
Spectrum Identification Results: + Scan (0.191-0.240 min) Sub (CTR-B-29. D (2a) 
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Figure S5. 1H NMR for N6-(2-bromoacetyl)-N2-((2-phenylacetyl)glycyl)-L-lysine (2b)
  
S-­‐9	  
	  
Figure S6.  13C NMR for N6-(2-bromoacetyl)-N2-((2-phenylacetyl)glycyl)-L-lysine (2b)
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Figure S7. Homonuclear 1H-1H COSY NMR for N6-(2-bromoacetyl)-N2-((2-
phenylacetyl)glycyl)-L-lysine (2b) 
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Figure S8. HPLC Data for 4/5 Alkene/Alcohol Mixture 
 
HPLC Data 
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Figure S9. LC-MS Data for 4/5 Alkene/Alcohol Mixture 
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A 
RT=2.45m 
Alcohol 
Figure S10. LC-MS Data for 4/5 Alkene/Alcohol Mixture 
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Peak 
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RT=3.50m 
Alkene 
Figure S11. LC-MS Data for 4/5 Alkene/Alcohol Mixture 
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Peak 
C 
Figure S12. LC-MS Data for 4/5 Alkene/Alcohol Mixture 
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Peak 
D 
Figure S13. LC-MS Data for 4/5 Alkene/Alcohol Mixture 
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Figure S14. 1H NMR of D2O Exchange on 4/5 Mixture 
1H NMR: 
7.5mg 4/5 in 
750uL DMSO 
	  
 
1H NMR: 
7.5mg 4/5 in 
750uL DMSO 
+ 14uL D2O 
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1H NMR: 
7.5mg 4/5 in 
750uL DMSO 
+ 30uL D2O 
 Figure S15.  D2O Exchange on 4/5 Mixture 
	  
 
1H NMR: 
7.5mg 4/5 in 
750uL DMSO 
+ 45uL D2O 
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1H NMR: 
7.5mg 4/5 in 
750uL DMSO 
+ 60uL D2O 
 Figure S16.  D2O Exchange on 4/5 Mixture 
 
 
COSY NMR: 
7.5mg 4/5 in 
750uL DMSO 
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Figure S17.  [A] Discontinuous assay demonstrating C-S bond formation. Assay result HPLC 
Chromatogram for [B] Control: 4/5 Mix + Buffer. [C] Control: HSCoA + 4/5 Mix + Buffer. [D] 
Trial 1: High conc. Enzyme + HSCoA + 4/5 Mix [E] Trial 2: Low conc. Enzyme + HSCoA + 4/5 
Mix + Buffer. [F] Trial 3: HSCoA + 4/5 Mix + AIBN + Buffer.5 
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 Figure S18. [A] Discontinuous assay demonstrating C-S bond formation of bisubstrate 6. 
[C] 
 
[D] 
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 Figure S19. [A] Discontinuous assay demonstrating C-S bond formation producing 
bisubstrate 6	  
[E] 
 
[F] 
 
S-­‐23	  
	  
Figure S20. A) MS and B) MS-MS Fragmentation Analysis of bisubstrate 6 produced by radical 
addition to alkene, after Solid Phase Extraction (SPE) Preparation. 
[A] 
 
[B] 
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Figure S21. Product-Based Transition-State Modeling (PBTSM) Expanded Description. 
Protocol for systematic remodeling of tetrahedral intermediate and substrate binding modes from 
product or bisubstrate bound crystal structures. Molecular minimization (MM) and molecular 
dynamics (MD) stages in the protocol are shown. Further details are presented in Experimental 
Procedures.	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